Brief: Chordate Medical Adopts Cost Reduction Program For Company Sale
Aug 21 (Reuters) - Chordate Medical Holding AB (publ) CMHM.ST: ADOPTS COST REDUCTION PROGRAM FOR COMPANY SALE TOGETHER WITH RECENTLY COMPLETED DIRECTED SHARE ISSUE OF APPROXIMATELY SEK 2.55 MILLION, INTENTION IS TO GIVE EXIT PROCESS AS MUCH TIME AS POSSIBLE Source text: ID:nMFN9jkvQw Further company coverage: CMHM.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Chordate Medical Holding AB (publ)
See all newsBrief: Chordate Applies For Delisting
Brief: Chordate Medical Holding Says Last Day Of Trading Is In March 2026
Brief: Chordate Medical To Enter Into Voluntary Liquidation
Brief: Chordate Board Proposes AGM To Resolve On Voluntary Liquidation And Delisting
Brief: Chordate Medical Holding Q2 Net Loss SEK 5.2 Mln